CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Update

CanSino Biologics Inc. (OTCMKTS:CASBF) saw a significant growth in short interest in November. As of November 30th, there was short interest totalling 14,800 shares, a growth of 37.0% from the November 15th total of 10,800 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 148.0 days.

CanSino Biologics Price Performance

CASBF remained flat at C$4.35 on Friday. CanSino Biologics has a one year low of C$1.86 and a one year high of C$4.35. The business has a 50 day moving average price of C$3.74 and a 200 day moving average price of C$2.90.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.